4CPS-312 Pharmaceutical interventions in a non-oncohaematological daily hospital

Autor: E Oñate Muzas, A Revuelta Amallo, E Tamayo Orbegozo, C Vila Gallego, U Blazquez Urtizberea, A Aguirrezabal Arredondo, S Vallinas Hidalgo, JA Dominguez Menendez, M Vara Urruchua

Publikováno v: Section 4: Clinical pharmacy services.

Background and importance The role of the pharmacist in the validation and dispensing of medications is already known. But the increasingly frequent use of high cost drugs makes that role essential for the sustainability of health systems. Aim and ob

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::3a2338b55a903767109deee77a1e5279
https://doi.org/10.1136/ejhpharm-2021-eahpconf.144

Eritrodisestesia palmo-plantar y doxorubicina liposomal no pegilada. A propósito de un caso

Autor: G. Segrelles-Bellmunt, E. Oñate-Muzás, A. Iruin-Sanz, E. Tamayo-Orbegozo

Publikováno v: Farmacia Hospitalaria. 35:46-47

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::29b7758cab36b3345695be2861cba292
https://doi.org/10.1016/j.farma.2010.03.002

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Hybrid Cell Membrane-Based Nanoplatforms for Enhanced Immunotherapy against Cancer and Infectious Diseases.

Autor: Peng X; School of Pharmaceutical Sciences (Shenzhen), Shenzhen Campus of Sun Yat-sen University, Shenzhen, 518107, China., Yang L; School of Pharmaceutical Sciences (Shenzhen), Shenzhen Campus of Sun Yat-sen University, Shenzhen, 518107, China., Yuan P; School of Pharmaceutical Sciences (Shenzhen), Shenzhen Campus of Sun Yat-sen University, Shenzhen, 518107, China., Ding X; School of Medicine, Sun Yat-sen University, Shenzhen, 518107, China.; State Key Laboratory of Anti-Infective Drug Discovery and Development, School of Pharmaceutical Sciences, Sun Yat-sen University, Guangzhou, 510006, China.

Publikováno v: Advanced healthcare materials [Adv Healthc Mater] 2024 Jul; Vol. 13 (19), pp. e2304477. Date of Electronic Publication: 2024 May 11.

A novel immunochemotherapy based on immunogenicity-activated and immunosuppression-reversed biomimetic nanoparticles.

Autor: Zuo, Huaqin, Tao, Junxian, Wang, Manli, Xie, Xiaoyan, Sun, Mei

Publikováno v: RSC Advances; 2022, Vol. 12 Issue 43, p28104-28112, 9p